|
Volumn 20, Issue 2, 2005, Pages 215-217
|
Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings
|
Author keywords
In 111 octreotide therapy; Neuroendocrine liver metastases; Ultrasonography
|
Indexed keywords
CELL DNA;
OCTREOTIDE;
PENTETATE INDIUM IN 111;
SOMATOSTATIN RECEPTOR;
ADULT;
AGED;
CANCER SCINTISCANNING;
CANCER STAGING;
CATHETERIZATION;
CLINICAL ARTICLE;
COMPUTER ASSISTED TOMOGRAPHY;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIAGNOSTIC IMAGING;
DRUG ACTIVITY;
DRUG TARGETING;
ECHOGRAPHY;
ELECTRON TRANSPORT;
FEMALE;
HUMAN;
HUMAN TISSUE;
INTRAHEPATIC BILE DUCT;
LIVER INJURY;
LIVER METASTASIS;
MALE;
NEUROENDOCRINE TUMOR;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TUMOR VOLUME;
ADULT;
AGED;
DNA;
FEMALE;
HUMANS;
INDIUM;
INDIUM RADIOISOTOPES;
LIVER;
LIVER NEOPLASMS;
MAGNETIC RESONANCE IMAGING;
MALE;
MICROSCOPY, ELECTRON;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEOPLASMS;
NEUROENDOCRINE TUMORS;
OCTREOTIDE;
PENTETIC ACID;
RADIONUCLIDE IMAGING;
TOMOGRAPHY, X-RAY COMPUTED;
ULTRASONICS;
ULTRASONOGRAPHY;
|
EID: 21044459815
PISSN: 10849785
EISSN: None
Source Type: Journal
DOI: 10.1089/cbr.2005.20.215 Document Type: Conference Paper |
Times cited : (21)
|
References (5)
|